Skip to main content
Sol-Gel Technologies Ltd. logo

Sol-Gel Technologies Ltd. — Investor Relations & Filings

Ticker · SLGL ISIN · IL0011417206 LEI · 5493003J2SQF7YM0BK11 US Manufacturing
Filings indexed 304 across all filing types
Latest filing 2023-07-27 Regulatory Filings
Country IL Israel
Listing US SLGL

About Sol-Gel Technologies Ltd.

http://www.sol-gel.com

Sol-Gel Technologies Ltd. is a dermatology company that develops and commercializes topical treatments for skin conditions. The company leverages a proprietary, silica-based microencapsulation technology to stabilize active ingredients and enable controlled drug delivery. Its portfolio includes commercialized products for acne vulgaris and rosacea. The development pipeline focuses on addressing unmet needs in rare dermatological diseases, with a lead candidate, patidegib gel, for the prevention of new basal cell carcinoma lesions in patients with Gorlin syndrome. Other therapeutic areas of interest include pachyonychia congenita and hyperkeratosis-related indications. The company's strategy involves identifying and developing promising dermatological assets to provide innovative formulations for patients.

Recent filings

Filing Released Lang Actions
6-K
Regulatory Filings
2023-07-27 English
Regulatory Filings 2023
Regulatory Filings
2023-07-24 English
6-K/A
Regulatory Filings
2023-07-20 English
Regulatory Filings 2023
Regulatory Filings
2023-06-27 English
6-K
Regulatory Filings
2023-06-21 English
6-K
Regulatory Filings
2023-06-14 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.